Package 63868-473-35

Brand: levocetirizine dihydrochloride

Generic: levocetirizine dihydrochloride
NDC Package

Package Facts

Identity

Package NDC 63868-473-35
Digits Only 6386847335
Product NDC 63868-473
Product ID 63868-473_62bd5a02-2f4d-697f-856c-7516352417c1
Description

1 BOTTLE in 1 CARTON (63868-473-35) / 35 TABLET, COATED in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2020-06-24
Brand levocetirizine dihydrochloride
Generic levocetirizine dihydrochloride
Sample Package No

Linked Drug Pages (1)

levocetirizine dihydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "62bd5a02-2f4d-697f-856c-7516352417c1", "openfda": {"unii": ["SOD6A38AGA"], "rxcui": ["855172"], "spl_set_id": ["61fb8bef-d868-adee-3237-d3268d603ba6"], "manufacturer_name": ["Chain Drug Marketing Association INC"]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (63868-473-35)  / 35 TABLET, COATED in 1 BOTTLE", "package_ndc": "63868-473-35", "marketing_start_date": "20200624"}], "brand_name": "levocetirizine dihydrochloride", "product_id": "63868-473_62bd5a02-2f4d-697f-856c-7516352417c1", "dosage_form": "TABLET, COATED", "pharm_class": ["Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "63868-473", "generic_name": "levocetirizine dihydrochloride", "labeler_name": "Chain Drug Marketing Association INC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "levocetirizine dihydrochloride", "active_ingredients": [{"name": "LEVOCETIRIZINE DIHYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA210375", "marketing_category": "ANDA", "marketing_start_date": "20200624", "listing_expiration_date": "20261231"}